London: A drug currently used to treat patients with osteoporosis can protect stem cells from ageing, a breakthrough study has found.
Scientists from the University of Sheffield discovered the drug zoledronate is able to extend the lifespan of mesenchymal stem cells by reducing DNA damage.
DNA damage is one of the most important mechanisms of ageing where stem cells lose their ability to maintain and repair the tissues in which they live and keep it working correctly.
The pioneering research shows the drug protects the stem cells from DNA damage enhancing their survival and maintaining their function.
"The drug enhances the repair of the damage in DNA occurring with age in stem cells in the bone. It is also likely to work in other stem cells too," said professor Ilaria Bellantuono from the University's department of metabolism.
"This drug has been shown to delay mortality in patients affected by osteoporosis but until now we didn't know why. These findings provide an explanation as to why it may help people to live longer," he added.
Approximately 50 per cent of over 75 year-old globally have three or more diseases at the same time such as cardiovascular disease, infections, muscle weakness and osteoporosis.
It is hoped this drug could be used to treat, prevent or delay the onset of such diseases rather than using a mixture of drugs.
"We are hopeful that this research will pave the way for a better cure for cancer patients and keeping older people healthier for longer by reducing the risk of developing multiple age-related diseases," the authors noted in a paper in the journal Stem Cells.
Scientists from the University of Sheffield discovered the drug zoledronate is able to extend the lifespan of mesenchymal stem cells by reducing DNA damage.
DNA damage is one of the most important mechanisms of ageing where stem cells lose their ability to maintain and repair the tissues in which they live and keep it working correctly.
"The drug enhances the repair of the damage in DNA occurring with age in stem cells in the bone. It is also likely to work in other stem cells too," said professor Ilaria Bellantuono from the University's department of metabolism.
Advertisement
Approximately 50 per cent of over 75 year-old globally have three or more diseases at the same time such as cardiovascular disease, infections, muscle weakness and osteoporosis.
Advertisement
"We are hopeful that this research will pave the way for a better cure for cancer patients and keeping older people healthier for longer by reducing the risk of developing multiple age-related diseases," the authors noted in a paper in the journal Stem Cells.
Advertisement
COMMENTS
Advertisement
Scientists Develop Breakthrough Anti-Ageing Drug That Extends Lifespan by 25% Sedentary Lifestyle? Here's What Happens To Your Body If You Don't Exercise Enough 10% Quota, Age Relaxations For Ex-Agniveers, Say CISF, BSF Chiefs World's Largest Isolated Tribe Makes Rare Appearance In New Footage Madhya Pradesh's CBI Move: Agency Needs Written Consent To Probe Cases Why BJP Lost Lok Sabha Polls In Uttar Pradesh - 6 Reasons In Party Report OpenAI Unveils Cheaper Small AI Model GPT-4o Mini Man Insulted By Employer's Son Takes Revenge, Robs Him Off Rs 3.5 Crore Norton Motorcycles To Be Launched In India; Six Motorcycles Announced For Global Markets Track Latest News Live on NDTV.com and get news updates from India and around the world.